Sonoma Pharmaceuticals Inc (SNOA)

Überblick Nachrichten Preisverlauf Financials Warum fällt SNOA? Forum Prognose Aktiensplit

Finanzdaten der Sonoma Pharmaceuticals Inc-Aktie (SNOA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	6.95% 4.015	3.754	3.564	3.579	3.391
Cost Of Revenue	14.60% 2.551	2.226	2.294	2.218	2.085
Gross Profit	4.19% 1.464	1.528	1.27	1.361	1.306
Operating Expenses	17.17% 2.559	2.184	2.301	2.211	2.479
Benefits Costs and Expenses	22.77% 5.257	4.282	4.483	4.042	4.388
Costs And Expenses	22.77% 5.257	4.282	4.483	4.042	4.388
Operating Income/Loss	66.92% -1.095	-0.656	-1.031	-0.85	-1.173
Income/Loss From Continuing Operations Before Tax	135.23% -1.242	-0.528	-0.919	-0.463	-0.997
Income Tax Expense/Benefit	100.40% -0.001	0.248	0.009	0.147	0.146
Income/Loss From Continuing Operations After Tax	59.92% -1.241	-0.776	-0.928	-0.61	-1.143
Net Income/Loss	441.92% -1.241	-0.229	-0.928	-0.61	-1.143
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	100.00% -	0.547	-	-	-
Basic Average Shares	1,223% 1.641	0.124	1.464	1.034	17.03
Diluted Average Shares	1,223% 1.641	0.124	1.464	1.034	17.03
Basic Earnings Per Share	94.87% -0.76	-0.39	-0.63	-0.59	-0.07
Diluted Earnings Per Share	94.87% -0.76	-0.39	-0.63	-0.59	-0.07
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

HIMS

$44.39

2.35%

RDY

$13.41

0.90%

ELAN

$22.85

3.16%

VTRS

$10.53

1.64%

NBIX

$141.96

0.87%

UTHR

$438.66

1.52%